Overall, there was a 15.8% incidence of migraines in the first 3 months following the procedure among people randomized to clopidogrel (Plavix) plus aspirin or aspirin alone. After this initial period ...

Atrial septal defect closure techniques have evolved considerably over recent decades. Traditional surgical repair, once the mainstay of treatment for congenital heart anomalies, has gradually been ...

NEW YORK - March 12, 2019-The Cardiovascular Research Foundation (CRF) is pleased to announce that the latest issue of Structural Heart: The Journal of the Heart Team features original research ...

Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The "PFO Closure Device Market - Global Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. In a landscape shaped by evolving ...

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced its development program for PerQseal ® ...

SAN FRANCISCO -- Surprisingly, a course of direct oral anticoagulation (DOAC) may be the safer choice for antithrombotic treatment after left atrial appendage (LAA) occlusion, according to the ANDES ...

The AI model was more efficient at detecting signatures of atrial septal defect (ASD) in electrocardiograms (ECG) than traditional methods. A study from Ann & Robert H. Lurie Children's Hospital of ...

A less invasive procedure for treating a congenital heart defect in children is a safe alternative to traditional surgery with no five-year difference in risk of death and is associated with a 62 ...

Patients being treated with dual-antiplatelet therapy (DAPT) consisting of clopidogrel plus aspirin following atrial septal defect (ASD) closure can safely discontinue clopidogrel after 3 months ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global heart valve repair and replacement devices market, and the market is poised to grow by USD 7.02 billion during 2019-2023 at a CAGR of ...